I want to share an update on what proactive steps OctariusRx is taking to keep our customers and our people safe while continuing to provide the exceptional services you rely on. These are unprecedented times and coronavirus (COVID-19) is having a dramatic impact on our lives and on many businesses. We want all our customers and patients to know we have a business continuity plan in place and will continue to provide all the services you are accustomed to.
Category: Patients
Welcome to our newest partners in medication safety!
We are thrilled to welcome our three newest partners, facilities who have asked us to help them enhance patient safety, reduce risks and increase survey success.
It’s National Glaucoma Awareness Month!
It’s National Glaucoma Awareness Month and as your consultant pharmacist we wanted to take this opportunity to remind you about scheduling your regular comprehensive eye exam.
Happy New Year!
We have some exciting plans in the works for 2020. As we begin a new year full of hope and promise, we’d like to wish you great success in achieving your dreams and goals. All the bests for an amazing 2020!
Merry Christmas!
Merry Christmas! What an incredible year 2019 has been and it couldn’t have happened without the support of our family, friends, team members and clients.
Happy Thanksgiving!
Thanksgiving is about friends, family and giving thanks. From our OctariusRx family to yours, thank you!
November is National Alzheimer’s Awareness Month
Every 65 seconds someone develops the disease. Do you know the ten early signs and symptoms of Alzheimer’s?
Happy Veterans Day!
On this special day, let us pause and salute all who have served and honor the tremendous sacrifices they have made.
Happy National Pharmacy Week!
As we celebrate National Pharmacy Week, I would like to take the time to thank our Consultant Pharmacists as well as supporting team members.
FDA approves Eli Lilly’s Baqsimi, the first treatment for severe hypoglycemia that can be administered without an injection
In this week's post we discuss the approval of Baqsimi nasal powder. This is the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.